Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition comprising bee venom-phospholipase A2 (bv-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity

Pharmaceutical composition comprising bee venom-phospholipase A2 (bv-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity

US Patent 9919035 · Granted Mar 20, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Organic electroluminescent compound and organic electroluminescent device compri2025
Cell culture sheet and large-capacity cell culture device including same2025
Lifting band2025
Cell culture sheet assembly for large-capacity incubator, and large-capacity inc2025
Organic electroluminescent compound and organic electroluminescent device compri2025
Plurality of host materials and organic electroluminescent device comprising the2025
Optical stack, and manufacturing method for same, and smart window including sam2025
Organic electroluminescent compound and organic electroluminescent device compri2025
Organic electroluminescent compound, organic electroluminescent material compris2025
Method for treating cancer based on expression levels of translationally control2024
LED patch for skin care apparatus and skin care apparatus including the same2024
Ultraviolet protection patch and application method thereof2024